Drug recall · January 8, 2025
ketamine inj 50 mg per 1 mL recall
Why: Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill in a 3mL pre-filled syringe, For IV or IM Use, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, This is a Compounded Drug. Hospital/Office Use Only. NDC 63037-137-25
- Lots / codes
Lot number: 242560008D, Use by Date 01/15/2025; 242970002D, Use by Date 02/25/2025
- Quantity
- 1,800 syringes
- Company
- Hikma Injectables USA Inc, Dayton, NJ
- Distribution
- Nationwide in the USA
- Initiated
- December 19, 2024 · Voluntary: Firm initiated
- Classified
- January 2, 2025
- Reported
- January 8, 2025
- Ended
- November 12, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ketamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.